24
Views
2
CrossRef citations to date
0
Altmetric
Miscellaneous

Millennium Pharmaceuticals

Pages 1605-1608 | Published online: 25 Feb 2005
 

Abstract

Millennium Pharmaceuticals is a public company, founded in 1993 and based in Cambridge, Massachusetts, that has pioneered the exploitation of genomic methods in the identification of novel therapeutic targets. By exploiting its technologies it was able to generate substantial revenues through strategic partnerships with companies such as Bayer, Aventis and Abbott. These revenues augmented the cash raised from its flotation and have enabled Millennium to revise its corporate strategic, by acquiring the product-driven pharmaceutical biotechnology companies Leukosite and COR Therapeutics, and evolve towards its aim of becoming an integrated pharmaceutical company. This analysis of its patenting activity since its inception indicates that genomic-related patent applications still currently account for most of its patenting activities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.